Screener
Bausch Health Companies BHC Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $1,299 | $1,309 |
| Restricted cash | 13 | 16 |
| Trade receivables, net | 2,191 | 2,351 |
| Inventories, net | 1,601 | 1,629 |
| Prepaid expenses and other current assets | 874 | 852 |
| Total current assets | 5,978 | 6,157 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's restricted cash?
- Bausch Health Companies (BHC) reported restricted cash of $13M in Q1 2026.
- How has Bausch Health Companies's restricted cash changed year-over-year?
- Bausch Health Companies's restricted cash decreased by 43.5% year-over-year, from $23M to $13M.
- What is the long-term trend for Bausch Health Companies's restricted cash?
- Over 4 years (2020 to 2025), Bausch Health Companies's restricted cash has grown at a -66.1% compound annual growth rate (CAGR), from $1.21B to $16M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Bausch Health Companies's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude